Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now KSE - Delayed Quote • KRW SD Biosensor, Inc (137310.KS) Follow Add holdings 9,120.00 +60.00 +(0.66%) At close: 3:30:30 PM GMT+9 All News Press Releases SEC Filings SD Biosensor Signs Tripartite MOU for R&D of New Products for Extensively Drug-Resistant Tuberculosis with Japan's RIT/JATA and Korea's International Tuberculosis Research Center SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, announced the signing of a tripartite memorandum of understanding (MOU) for the research and development (R&D) of new products targeting extensively drug-resistant tuberculosis using its Point-of-Care (POC) molecular diagnostic platform "STANDARD M10" (hereinafter, "M10"). The MOU was signed with the Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (hereinafter, "RIT/JATA"), and Korea's Inter SD Biosensor and the NCCD Discuss Cooperation Measures to Eradicate Infectious Diseases SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, stated that the National Center for Communicable Diseases, Mongolia (NCCD), visited SD Biosensor's Cheongju and Jeungpyeong Factories on November 8 and that the NCCD and SD Biosensor discussed cooperation measures to eradicate infectious diseases. Performance Overview Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) Return 137310.KS KOSPI Composite Index (^KS11) YTD -11.28% +5.25% 1-Year -8.01% -3.72% 3-Year -80.29% -6.62%